Does LENVATINIB Cause Musculoskeletal stiffness? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Musculoskeletal stiffness have been filed in association with LENVATINIB (Lenvima). This represents 0.2% of all adverse event reports for LENVATINIB.
69
Reports of Musculoskeletal stiffness with LENVATINIB
0.2%
of all LENVATINIB reports
4
Deaths
33
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From LENVATINIB?
Of the 69 reports, 4 (5.8%) resulted in death, 33 (47.8%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
Yes, Musculoskeletal stiffness is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which LENVATINIB Alternatives Have Lower Musculoskeletal stiffness Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE